Last reviewed · How we verify

NCT05163431

Dimensional Validation of the Hallux Valgus Orthosis

Completed NA Last updated 6 March 2023
What this trial tests

NA trial testing Hallux Valgus orthosis in Hallux Valgus in 4 participants. Completed in 30 September 2022.

Timeline
20 July 2021
Primary endpoint
30 September 2022
30 September 2022

Quick facts

Lead sponsorTOPMED
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment4
Start date20 July 2021
Primary completion30 September 2022
Estimated completion30 September 2022
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

TOPMED

Who can join

Adults 18 to 65, any sex, with Hallux Valgus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this project is to optimize the design of the orthosis by establishing the key volumetric characteristics of the custom iterations in order to subsequently transpose them to a standard model and establish the increment proportions of the different sizes. The final product should reduce the pain by repositioning the phalanges of the first toe with the first metatarsal in its axis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Hallux Valgus

Currently open trials in the same condition.

Other TOPMED trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05163431.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing